Skip to main content

Table 6 NSCLC patients (stage I, II and III) with surgical resection in the Pre-EBUS cohort compared to the Post-EBUS cohort

From: Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study

 

Pre-EBUS cohort (n = 97)

Post-EBUS cohort (n = 153)

 

NSCLC stage

Surgery n (%)

No surgery n (%)

Surgery n (%)

No surgery n (%)

p

I

16 (59.3)

11 (40.7)

36 (65.5)

19 (34.5)

0.378a

II

2 (16.7)

10 (83.3)

13 (56.5)

10 (43.5)

0.026a,*

III

5 (8.6)

53 (91.4)

3 (4.0)

72 (96.0)

0.228b

Total

23 (23.7)

74 (76.3)

52 (34)

101 (66)

 
  1. *p < 0.05
  2. aPearson’s chi squared test
  3. bFisher’s exact test
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us